Small cell lung cancer (SCLC) accounts for 13-15% of all new lung cancer cases and
represents the sixth most commonly diagnosed cancer in the US. However, it is an …

Small-cell lung cancer (SCLC) is the third most common histology of lung cancers and is
extremely aggressive and highly metastatic. Although SCLC responds well to radiation and …

We performed comprehensive proteogenomic characterization of small cell lung cancer
(SCLC) using paired tumors and adjacent lung tissues from 112 treatment-naive patients …

Simple Summary Our study centers on refining the diagnosis of small-cell lung cancer
(SCLC), a unique subtype with distinct therapeutic implications compared to other lung …

Small cell lung cancer (SCLC) is a recalcitrant malignancy. Conquering it will require deep
insight into its biology. In this issue of Cell, Liu and colleagues describe proteomic and …

Background and objective Small cell lung cancer (SCLC) is the most aggressive type of lung
carcinoma with high metastatic potential and chemoresistance upon relapse. Cancer cells …

To overcome hurdles in identifying key kinases in small cell lung cancer (SCLC), we
integrated a target-agnostic phenotypic screen of kinase inhibitors with target identification …

Background Small cell lung cancer (SCLC) is a devastating subtype of lung cancer, and its
biological, clinical and genetic characteristics differ from those associated with non-small …

Background Small cell lung cancer (SCLC) is a heterogeneous malignancy with dismal
prognosis. As molecular subtyping of SCLC with distinct genomic and transcriptional profiles …

Introduction Small cell lung cancer (SCLC) is a heterogeneous malignancy with dismal
prognosis. However, few studies have conducted on the metabolic heterogeneity in SCLC …